相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Ibon Martinez-Arranz et al.
HEPATOLOGY (2022)
The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease
Britt E. Heidemann et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits
Tomonari Koike et al.
ATHEROSCLEROSIS (2021)
Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk
Anita M. van den Hoek et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
Alessandro Mantovani et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)
Relationship between Heart Disease and Liver Disease: A Two-Way Street
Hamza El Hadi et al.
CELLS (2020)
Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report
Mengmeng Guo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology
Anita M. van den Hoek et al.
CELLS (2020)
Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of nonalcoholic steatohepatitis in Ldlr-/-.Leiden mice
Kanita Salic et al.
PLOS ONE (2019)
Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice
Sophie A. H. Jacobs et al.
NUTRIENTS (2019)
Diet-Independent Correlations between Bacteria and Dysfunction of Gut, Adipose Tissue, and Liver: A Comprehensive Microbiota Analysis in Feces and Mucosa of the Ileum and Colon in Obese Mice with NAFLD
Eveline Gart et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Soo Lim et al.
OBESITY REVIEWS (2019)
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
Juan Pablo Arab et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis
Zhao Dong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Extra-Virgin Olive Oil with Natural Phenolic Content Exerts an Anti-Inflammatory Effect in Adipose Tissue and Attenuates the Severity of Atherosclerotic Lesions in Ldlr-/-.Leiden Mice
Amparo Luque-Sierra et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
dynGENIE3: dynamical GENIE3 for the inference of gene networks from time series expression data
Van Anh Huynh-Thu et al.
SCIENTIFIC REPORTS (2018)
Key Inflammatory Processes in Human NASH Are Reflected in LdIr(-/-).Leiden Mice: A Translational Gene Profiling Study
Martine C. Morrison et al.
FRONTIERS IN PHYSIOLOGY (2018)
Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study
Shuaib M. Abdullah et al.
CIRCULATION (2018)
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-.Leiden Mice
Martine C. Morrison et al.
HEPATOLOGY COMMUNICATIONS (2018)
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model
Arianne van Koppen et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2018)
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
Hua-Zhong Ying et al.
MOLECULAR MEDICINE REPORTS (2017)
Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases
Nima Motamed et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Butyrate Reduces HFD-Induced Adipocyte Hypertrophy and Metabolic Risk Factors in Obese LDLr-/-. Leiden Mice
Charlotte E. Pelgrim et al.
NUTRIENTS (2017)
A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice
Marieke H. Schoemaker et al.
PLOS ONE (2017)
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients
Andreas Teufel et al.
GASTROENTEROLOGY (2016)
Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice
M. C. Morrison et al.
INTERNATIONAL JOURNAL OF OBESITY (2016)
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven M. Francque et al.
JOURNAL OF HEPATOLOGY (2016)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
Jessica L. Mellinger et al.
JOURNAL OF HEPATOLOGY (2015)
Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin
Susan Kuehnast et al.
EUROPEAN HEART JOURNAL (2015)
Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis
Licia Polimeni et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)?
Zoon Tariq et al.
LIVER INTERNATIONAL (2014)
Establishment of a General NAFLD Scoring System for Rodent Models and Comparison to Human Liver Pathology
Wen Liang et al.
PLOS ONE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Human Apolipoprotein A-II Protects Against Diet-Induced Atherosclerosis in Transgenic Rabbits
Yao Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Methods of accelerated atherosclerosis in diabetic patients
Gerard Pasterkamp
HEART (2013)
Insulin Resistance, Hyperglycemia, and Atherosclerosis
Karin E. Bornfeldt et al.
CELL METABOLISM (2011)
Triglycerides and Cardiovascular Risk
K. E. L. Harchaoui et al.
CURRENT CARDIOLOGY REVIEWS (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Reduced atherosclerotic lesion size in P-selectin deficient apolipoprotein E-knockout mice fed a chow but not a fat diet
Marie-Claude Bourdillon et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice
DJM Delsing et al.
CIRCULATION (2001)
NF-κB:: pivotal mediator or innocent bystander in atherogenesis?
T Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
